Side effects of Alnylam's gene-silencing drug raise concerns, shares slip

Alnylam Pharmaceuticals Inc's late-stage trial data on its new gene silencing drug cast doubt on its safety, even as results revealed its effectiveness in treating a rare, painful disease.

from Reuters: Health https://ift.tt/2TwMec1
via IFTTT

• Tweet
• Share
• Share
• Share
• Share